Improving the Quality of Care While Reducing Costs

Our remote monitoring technology has helped us build the world’s largest cardiac data network, making care more accurate, comprehensive and efficient.

4,000,000,000+
Processing over 4 billion heartbeats a day

1,000,000+
Monitoring over 1 Million patients per year

30,000+
Each month more than 30,000 physicians refer patients to our products

1,000,000+
Provided over 1 million reports to physicians with information for diagnosis and therapy management

50,000+
Over 50,000 monitoring devices – 29 U.S. patents and 34 international patents issued

$300,000,000+
Over $300 million invested in the technology and service platform

BioTel Heart is the leading provider of remote cardiac monitoring diagnostic services.

See Why

Need help with your heart monitor?

Find product details, quick start guides and more at myheartmonitor.com.

Visit myheartmonitor.com

BioTelemetry Research is an industry leader in clinical trials testing services, monitoring, data, and scientific consulting.

Learn More

Latest News

BioTelemetry, Inc. Enters Agreement to Provide Cardiac Monitoring for Apple’s Heart Study

BioTelemetry, Inc. (NASDAQ:BEAT), the leading mobile and wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today a partnership with Apple (NASDAQ:AAPL) to provide cardiac monitoring services in conjunction with the Apple Heart Study.

November 30, 2017

BioTelemetry Research and AMRA Raise the Standard for Medical Imaging in NASH/NAFLD Clinical Trials

BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced that BioTelemetry Research, their leading global imaging and cardiac core lab, and AMRA, the international leader in body composition analysis, have formed an exclusive alliance for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) clinical trials.

October 25, 2017

BioTelemetry, Inc. to Release Second Quarter 2017 Earnings Results on August 8, 2017

BioTelemetry, Inc. (NASDAQ:BEAT) will release its second quarter 2017 earnings on Tuesday, August 8 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Tuesday, August 8, 2017. The broadcast will be available through the investor information section of the BioTelemetry website www.gobio.com.

July 31, 2017